Actionnariat et activité des initiés pour Damora Therapeutics, Inc. (GLTO): transactions des initiés, déclarations de trading du Sénat et de la Chambre américaine et actions en circulation. Suivez comment dirigeants et politiciens négocient le titre.
Prix
| Prix | $21.58 |
| Capitalisation | $34M |
| Bourse | NASDAQ |
| Pays | US |
Transactions d'Initiés Récentes
| Date | Initié | Type | Actions | Valeur |
|---|---|---|---|---|
| 2026-02-09 | Bruno Julianne | M-Exempt | 129,000 | |
| 2026-02-09 | Bruno Julianne | M-Exempt | 129 | |
| 2026-02-09 | Fairmount Funds Management LLC | M-Exempt | 5,809,000 | |
| 2026-02-09 | Fairmount Funds Management LLC | M-Exempt | 2,904,000 | |
| 2026-02-09 | Fairmount Funds Management LLC | M-Exempt | 5,809 | |
| 2026-02-09 | Fairmount Funds Management LLC | M-Exempt | 2,904 | |
| 2026-01-05 | Sattarzadeh Sherwin | A-Award | 444,209 | $9.7M |
| 2026-01-05 | Sattarzadeh Sherwin | A-Award | 190,376 | |
| 2026-01-05 | Sattarzadeh Sherwin | |||
| 2026-01-05 | Hewes L. Becker | A-Award | 528,603 | $11.5M |
Bilan (10 ans)
| Année | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Trésorerie | $31.0M | $11.3M | $163.6M | $62.6M | $32.8M | $21.5M | $14.2M | $257.6M |
| Placements à Court Terme | 0 | 0 | 0 | $37.6M | $27.4M | $11.7M | 0 | 0 |
| Créances | $989000 | $41.1M | $2.2M | $2.3M | $1.4M | $1.7M | $881000 | $899000 |
| Stocks | $3.0M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Actifs Courants | $35.0M | $56.1M | $169.3M | $110.1M | $63.9M | $36.8M | $16.8M | $260.4M |
| Immobilisations Corporelles | 0 | $298000 | $885000 | $1.0M | $1.2M | $325000 | $130000 | $104000 |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Actifs Incorporels | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Actifs Totaux | $35.1M | $56.6M | $171.6M | $122.2M | $73.2M | $38.2M | $17.1M | $260.5M |
| Dettes Fournisseurs | $1.4M | $3.3M | $2.9M | $1.5M | $3.4M | $1.7M | $377000 | $444000 |
| Dette à Court Terme | 0 | $87000 | 0 | 0 | 0 | 0 | 0 | 0 |
| Passifs Courants | $4.4M | $7.9M | $5.6M | $4.5M | $11.1M | $5.8M | $1.2M | $20.1M |
| Dette à Long Terme | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Passifs Totaux | $4.4M | $8.1M | $6.1M | $5.0M | $11.4M | $5.9M | $1.3M | $20.1M |
| Réserves | -$33.0M | -$69.5M | -$104.4M | -$156.1M | -$217.7M | -$256.1M | -$277.5M | -$487.4M |
| Capitaux Propres | $30.7M | $48.5M | $165.5M | $117.2M | $61.8M | $32.3M | $15.8M | $240.4M |
| Dette Totale | 0 | $298000 | $915000 | $847000 | $804000 | $249000 | $73000 | $68000 |
| Dette Nette | -$31.0M | -$11.0M | -$162.7M | -$99.3M | -$59.4M | -$32.9M | -$14.1M | -$257.6M |
| Fonds de Roulement | $30.5M | $48.2M | $163.7M | $105.6M | $52.8M | $30.9M | $15.6M | $240.4M |
Santé financière
| Dette / Capitaux propres | 0.00 |
| Ratio de liquidité | 19.73 |
Rentabilité
| Rentabilité des capitaux propres | -82.56% |
| Rentabilité du capital investi | -52.44% |
| Rentabilité des actifs | -48.35% |
| Marge brute | 0.00% |
| Marge opérationnelle | 0.00% |
| Marge nette | 0.00% |
Entreprises liées: ACXP · ADIL · APRE · APVO · BCDA · INAB · KPRX
Explorer le secteur: Healthcare · Medical - Pharmaceuticals
Plus de sections de GLTO: Vue d'ensemble · Financiers · Valorisation · Statistiques · Estimations · Technique · Actualités · Événements
Découvrir plus: Radar — signaux d'actions sous-évaluées · Académie d'Investissement — apprenez à analyser les actions